DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Angiotensinamide
Angiotensinamide
Partial Agreement in the Social and Public Health Field
General Agreement on Tariffs Andtrade
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Marrakesh Agreement Establishing the World Trade Organization
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Stembook 2018.Pdf
Medicines Regulations 1984 (SR 1984/143)
Amlodipine Besilate/Ancrod 1215
Summary of Product Characteristics, Labelling and Package Leaflet
Pharmaceuticals Appendix
Council of Europe Committee of Ministers (Partial
Annex I List of the Names, Pharmaceutical Forms
Marrakesh Agreement Establishing the World Trade Organization
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2016) Annotated for Statistical Reporting Purposes
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Top View
)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED
Customs Tariff - Schedule Xxi - 1
Australian Statistics on Medicines 2009
Pharmaceutical Appendix to the Tariff Schedule 2
Computational Prediction of Potential Inhibitors of the Main Protease of SARS-Cov-2
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
General Agreement on Tariffs Andtrade
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
(12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
ICD-10-CM TABLE of DRUGS and CHEMICALS
Pharmaceutical Appendix to the Tariff Schedule 2
Giapreza 4930
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Medicines Regulations 1984 (SR 1984/143)
ICD-10-CM Table of Drugs 2019
International Classification of Procedures in Medicine
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Active Substance: Ramipril + Furosemide Pharmaceutical Form(S)/Strength: Capsules, 5Mg/20Mg Capsules, 5Mg/40Mg P-RMS: AT/H/PSUR/0008/002 Date of FAR: 14.11.2011
Summary of Product Characteristics